List of Tables
Table 1. Global Long-acting Anti-HIV Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-acting Anti-HIV Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-acting Anti-HIV Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-acting Anti-HIV Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-acting Anti-HIV Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-acting Anti-HIV Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-acting Anti-HIV Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-acting Anti-HIV Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-acting Anti-HIV Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-acting Anti-HIV Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-acting Anti-HIV Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Long-acting Anti-HIV Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Anti-HIV Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-acting Anti-HIV Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Anti-HIV Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-acting Anti-HIV Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Long-acting Anti-HIV Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Long-acting Anti-HIV Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Long-acting Anti-HIV Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Long-acting Anti-HIV Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-acting Anti-HIV Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Long-acting Anti-HIV Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-acting Anti-HIV Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Long-acting Anti-HIV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-acting Anti-HIV Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Long-acting Anti-HIV Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-acting Anti-HIV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-acting Anti-HIV Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Long-acting Anti-HIV Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-acting Anti-HIV Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-acting Anti-HIV Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-acting Anti-HIV Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-acting Anti-HIV Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-acting Anti-HIV Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-acting Anti-HIV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-acting Anti-HIV Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-acting Anti-HIV Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-acting Anti-HIV Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-acting Anti-HIV Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-acting Anti-HIV Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-acting Anti-HIV Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Long-acting Anti-HIV Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Long-acting Anti-HIV Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Long-acting Anti-HIV Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Long-acting Anti-HIV Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-acting Anti-HIV Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-acting Anti-HIV Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Long-acting Anti-HIV Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-acting Anti-HIV Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Long-acting Anti-HIV Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Long-acting Anti-HIV Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Long-acting Anti-HIV Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Long-acting Anti-HIV Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-acting Anti-HIV Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-acting Anti-HIV Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Long-acting Anti-HIV Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. ViiV Healthcare Company Information
Table 71. ViiV Healthcare Description and Business Overview
Table 72. ViiV Healthcare Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. ViiV Healthcare Long-acting Anti-HIV Drugs Product
Table 74. ViiV Healthcare Recent Developments/Updates
Table 75. Janssen Pharmaceuticals Company Information
Table 76. Janssen Pharmaceuticals Description and Business Overview
Table 77. Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Pharmaceuticals Long-acting Anti-HIV Drugs Product
Table 79. Janssen Pharmaceuticals Recent Developments/Updates
Table 80. Gilead Sciences Company Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Gilead Sciences Long-acting Anti-HIV Drugs Product
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Theratechnologies Company Information
Table 86. Theratechnologies Description and Business Overview
Table 87. Theratechnologies Long-acting Anti-HIV Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Theratechnologies Long-acting Anti-HIV Drugs Product
Table 89. Theratechnologies Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Long-acting Anti-HIV Drugs Distributors List
Table 93. Long-acting Anti-HIV Drugs Customers List
Table 94. Long-acting Anti-HIV Drugs Market Trends
Table 95. Long-acting Anti-HIV Drugs Market Drivers
Table 96. Long-acting Anti-HIV Drugs Market Challenges
Table 97. Long-acting Anti-HIV Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting Anti-HIV Drugs
Figure 2. Global Long-acting Anti-HIV Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-acting Anti-HIV Drugs Market Share by Type: 2025 & 2032
Figure 4. Single Drug Product Picture
Figure 5. Combination Preparation Product Picture
Figure 6. Global Long-acting Anti-HIV Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Long-acting Anti-HIV Drugs Market Share by Application: 2025 & 2032
Figure 8. HIV Prevention
Figure 9. HIV Treatment
Figure 10. Global Long-acting Anti-HIV Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Long-acting Anti-HIV Drugs Market Size (US$ Million), 2021–2032
Figure 12. Global Long-acting Anti-HIV Drugs Sales (K Units), 2021–2032
Figure 13. Global Long-acting Anti-HIV Drugs Average Price (US$/Unit), 2021–2032
Figure 14. Long-acting Anti-HIV Drugs Report Years Considered
Figure 15. Long-acting Anti-HIV Drugs Sales Share by Manufacturers in 2025
Figure 16. Global Long-acting Anti-HIV Drugs Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Long-acting Anti-HIV Drugs Players: Market Share by Revenue in Long-acting Anti-HIV Drugs in 2025
Figure 18. Long-acting Anti-HIV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Long-acting Anti-HIV Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Long-acting Anti-HIV Drugs Sales Market Share by Country (2021–2032)
Figure 21. North America Long-acting Anti-HIV Drugs Revenue Market Share by Country (2021–2032)
Figure 22. United States Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Long-acting Anti-HIV Drugs Sales Market Share by Country (2021–2032)
Figure 25. Europe Long-acting Anti-HIV Drugs Revenue Market Share by Country (2021–2032)
Figure 26. Germany Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Long-acting Anti-HIV Drugs Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Long-acting Anti-HIV Drugs Revenue Market Share by Region (2021–2032)
Figure 33. China Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Long-acting Anti-HIV Drugs Sales Market Share by Country (2021–2032)
Figure 41. Latin America Long-acting Anti-HIV Drugs Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Long-acting Anti-HIV Drugs Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Long-acting Anti-HIV Drugs Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Long-acting Anti-HIV Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Long-acting Anti-HIV Drugs by Type (2021–2032)
Figure 52. Global Revenue Market Share of Long-acting Anti-HIV Drugs by Type (2021–2032)
Figure 53. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Long-acting Anti-HIV Drugs by Application (2021–2032)
Figure 55. Global Revenue Market Share of Long-acting Anti-HIV Drugs by Application (2021–2032)
Figure 56. Global Long-acting Anti-HIV Drugs Price (US$/Unit) by Application (2021–2032)
Figure 57. Long-acting Anti-HIV Drugs Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
